Trial intelligence / Profile preview

Lactase Eurofarma vs Lactaid in Lactose Intolerance

NCT01145586Phase 3Completed

Sponsor
Eurofarma
Start
Jun 2011
Primary completion
Mar 2012
Modality
Replacement Enzymes
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of lactase in lactose intolerance (2 arms), sponsored by Eurofarma. Primary endpoint: Hydrogen value in the expired air. Started Jun 2011; status: completed.

02

Drugs

lactase
03

Conditions

lactose intolerance

Beyond the preview

Go deeper on NCT01145586.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01145586.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call